Academic Journal

Teclistamab versus real-world physician’s choice of therapy in triple-class exposed relapsed/refractory multiple myeloma

التفاصيل البيبلوغرافية
العنوان: Teclistamab versus real-world physician’s choice of therapy in triple-class exposed relapsed/refractory multiple myeloma
المؤلفون: Amrita Krishnan, Ajay K Nooka, Ajai Chari, Alfred L Garfall, Thomas G Martin, Sandhya Nair, Xiwu Lin, Keqin Qi, Anil Londhe, Lixia Pei, Eric Ammann, Rachel Kobos, Jennifer Smit, Trilok Parekh, Alexander Marshall, Mary Slavcev, Saad Z Usmani
المصدر: Journal of Comparative Effectiveness Research, Vol 12, Iss 6 (2023)
بيانات النشر: Becaris Publishing Limited, 2023.
سنة النشر: 2023
المجموعة: LCC:Public aspects of medicine
مصطلحات موضوعية: b-cell maturation antigen, bispecific antibody, comparative effectiveness, indirect treatment comparison, majestec-1, Public aspects of medicine, RA1-1270
الوصف: Aim: We compared the effectiveness of teclistamab versus real-world physician’s choice of therapy (RWPC) in triple-class exposed relapsed/refractory multiple myeloma. Materials & methods: MajesTEC- 1 eligibility criteria were applied to the RWPC cohort. Baseline covariate imbalances were adjusted using inverse probability of treatment weighting. Overall survival, progression-free survival and time to next treatment were compared. Results: After inverse probability of treatment weighting, baseline characteristics were similar between cohorts (teclistamab, n = 165; RWPC, n = 364 [766 observations]). Teclistamab treated patients had numerically better overall survival (hazard ratio [HR]: 0.82 [95% CI: 0.59– 1.14]; p = 0.233) and significantly greater progression-free survival (HR: 0.43 [0.33–0.56]; p < 0.0001) and time to next treatment (HR: 0.36 [0.27–0.49]; p < 0.0001) versus the RWPC cohort. Conclusion: Teclistamab offered clinical benefit over RWPC in triple-class exposed relapsed/refractory multiple myeloma.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2042-6313
Relation: https://doaj.org/toc/2042-6313
DOI: 10.57264/cer-2022-0186
URL الوصول: https://doaj.org/article/d2234f01c82748d787b0b8d1a00b2e7e
رقم الانضمام: edsdoj.2234f01c82748d787b0b8d1a00b2e7e
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20426313
DOI:10.57264/cer-2022-0186